-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Aileron Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2017 to Q1 2024.
- Aileron Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $59K, a 37.2% increase year-over-year.
- Aileron Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $119K, a 29.6% decline from 2022.
- Aileron Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $169K, a 39.7% increase from 2021.
- Aileron Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2021 was $121K, a 25.8% decline from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)